γ-glutamyl cysteine synthetase up-regulates glutathione and multidrug resistance-associated protein in patients with chemoresistant epithelial ovarian cancer

Clinical Cancer Research

Volumn 4, Issue 7, 1998, Pages 1737-1741

  Kigawa, Junzo ^a   Minagawa, Yukihisa ^a   Cheng, Xiusi ^a   Terakawa, Naoki ^a  

^a TOTTORI UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

GLUTAMATE CYSTEINE LIGASE; GLUTATHIONE; MULTIDRUG RESISTANCE PROTEIN;

ARTICLE; CELL LEVEL; CONTROLLED STUDY; DRUG METABOLISM; DRUG RESPONSE; FEMALE; GENE EXPRESSION; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; OVARY CANCER; PRIORITY JOURNAL; REGULATORY MECHANISM;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; ATP-BINDING CASSETTE TRANSPORTERS; COMBINED MODALITY THERAPY; FEMALE; GLUTAMATE-CYSTEINE LIGASE; GLUTATHIONE; HUMANS; MIDDLE AGED; MULTIDRUG RESISTANCE-ASSOCIATED PROTEINS; NEOPLASM PROTEINS; OVARIAN NEOPLASMS; UP-REGULATION;

EID: 0031745799     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Muggia, F. M. Cisplatin update. Semin. Oncol., 8: 1-4, 1991.
2. Kigawa, J., Minagawa, Y., Ishihara, H., Kanamori, Y., and Terakawa, N. Tumor DNA ploidy and prognosis of patients with serous cystadenocarcinoma of the ovary. Cancer (Phila.), 72: 804-808, 1993.
3. Andrews, P. A., Velury, S., Mann, S. C., and Howell, S. B. Cis-Diamminedichloroplatinum (II) accumulation in sensitive and resistant human ovarian carcinoma cells. Cancer Res., 48: 68-73, 1988.
4. Andrews, P. A., and Howell, S. B. Cellular pharmacology of cisplatin: perspectives on mechanisms of acquired resistance. Cancer Cell, 2: 35-43, 1990.
5. Godwin, A. K., Meister, A., O'Dwyer, P. J., Huang, C. S., Hamilton, T. C., and Anderson, M. E. High resistance to cisplatin in human ovarian cancer cell lines is associated with marked increase of glutathione synthesis. Proc. Natl. Acad. Sci. USA, 89: 3070-3074, 1992.
6. Fujiwara, Y., Sugimoto, Y., Kasahara, K., Bungo, M., Yamakido, M., Tew, K. D., and Saijo, N. Determinants of drug response in a cisplatin-resistant human lung cancer cell line. Jpn. J. Cancer Res., 181: 527-535, 1990.
7. Kasahara, K., Fujiwara, Y., Nishio, K., Ohmori, T., Sugimoto, Y., Komiya, K., Mastuda, T., and Saijo, N. Metallothionein content correlates with the sensitivity of human small cell lung cancer cell lines to cisplatin. Cancer Res., 51: 3237-3242, 1991.
8. Meister, A. Selective modification of glutathione metabolism. Science (Washington DC), 220: 472-477, 1993.
9. Jedlitschky, G., Leier, I., Buchholz, U., Bamouin, K., Kurz, G., and Keppler, D. Transport of glutathione, glucuronate, and sulfate conjugates by the MRP gene-encoded conjugate export pump. Cancer Res., 56: 988-994, 1996.
10. Lautier, D., Canitrot, Y., Deeley, R. G., and Cole, S. P. Multidrug resistance mediated by the multidrug resistance protein (MRP) gene. Biochem. Pharmacol., 52: 967-977, 1996.
11. Ishikawa, T., Bao, J. J., Yamane, Y., Akimaru, K., Frindrich, K., Wright, C. D., and Kuo, M. T. Coordinated induction of MRP/GS-X pump and γ-glutamylcysteine synthetase by heavy metals in human leukemia cells. J. Biol. Chem., 271: 14981-14988, 1996.
12. Chomcynski, P., and Sacchi, N. Single-step method of DNA isolation by acid guanidinium thiocyanate-chloroform extraction. Anal. Biochem., 162: 156-159, 1987.
13. Kuo, M. T., Bao, J. J., Curley, S. A., Ikeguchi, M., Johnston, D. A., and Shikawa, T. Frequent coordinated overexpression of the MRP/GS-X pump and γ-glutamylcysteine synthetase genes in human colorectal cancers. Cancer Res., 56: 3642-3644, 1996.
14. Bradford, M. M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem., 72: 248-254, 1976.
15. Owens, C. W. I., and Belcher, R. V. A colorimentric micro-method for the determination of glutathione. Biochem. J., 94: 705-711, 1965.
16. Yao, K. S., Godwin, A. K., Johnson, S. W., Ozols, R. F., O'Dwyer, P. J., and Hamilton, T. C. Evidence for altered regulation of γ-glutamylcysteine synthetase gene expression among cisplatin-sensitive and cisplatin-resistant human ovarian cancer cell lines. Cancer Res., 55: 4367-4374, 1995.
17. Shen, H., Ranganathan, S., Kuzmich, S., and Tew, K. D. Influence of ethacrynic acid on glutathione S-transferase π transcript and protein half-lives in human colon cancer cells. Biochem. Pharmacol., 50: 1233-1238, 1995.
18. El-akawi, Z., Abu-hadid, M., Perez, R., Glavy, J., Zdanowicz, J., Creaven, P. J., and Pendyala, L. Altered glutathione metabolism in oxaliplatin resistant ovarian carcinoma cells. Cincer Lett., 105: 5-14, 1996.
19. Doroshow, J. H., Metz, M. Z., Matsumoto, L., Winters, K. A., Sakai, M., Muramastu, M., and Kane, S. E. Transduction of NIH 3T3 cells with a retrovirus carrying both human MDR1 and glutathione S-transferase-π produces broad-range multidrug resistance. Cancer Res., 55: 4073-4078, 1995.
20. Kido, Y., Khokhar, A. R., and Siddik, Z. H. Glutathione-mediated modulation of tetraplatin activity against sensitive and resistant tumor cells. Biochem. Pharmacol., 47: 1635-1642, 1994.
21. Goto, S., Yoshida, K., Morikawa, T., Urata, Y., Suzuki, K., and Kondo, T. Augmentation of transport for cisplatin-glutathione adduct in cisplatin-resistant cancer cells. Cancer Res., 55: 4297-4301, 1995.
22. Britten, R. A., Green, J. A., and Warenius, H. M. Cellular glutathione (GSH) and glutathione S-transferase (GST) activity in human ovarian tumor biopsies following exposure to alkylating agents. Int. J. Radiat. Oncol. Biol. Phys., 24: 527-531, 1992.
23. Green, J. A., Robertson, L. J., and Clark, A. H. Glutathione S-transferase expression in benign and malignant ovarian tumors. Br. J. Cancer, 68: 235-239, 1993.
24. Bock, K. W., Munzel, P. A., Rohrdanz, E., Schrenk, D., and Eriksson, L. C. Persistently increased expression of a 3-methylcholanthrene-inducible phenol uridine diphosphate-glucuronosyltransferase in rat hepatocyte nodules and hepatocellar carcinomas. Cancer Res., 50: 3569-3573, 1990.
25. Cheng, X., Kigawa, J., Minagawa, Y., Kanamori, Y., Itamochi, H., Okada, M., and Terakawa, N. Glutathione S-transferase- expression and glutathione concentration in ovarian carcinoma before and after chemotherapy. Cancer (Phila.), 79: 521-527, 1997.
26. Ciaccio, P. J., Shen, H., Kruh, G. D., and Tew, K. D. Effect of chronic ethacrynic acid exposure on glutathione conjugation and MRP expression in human colon tumor cells. Biochem. Biopys. Res. Commun., 222: 111-115, 1996.
27. Nooter, K., and Stoter, G. Molecular mechanisms of multidrug resistance in cancer chemotherapy. Pathol. Res. Pract., 92: 768-780, 1996.
28. Norris, M. D., Bordow, S. B., Marshall, G. M., Haber, P. S., Cohn, S. L., and Haber, M. Expression of the gene for multidrug-resistance-associated protein and outcome in patients with neuroblastoma. N. Engl. J. Med., 334: 231-238, 1996.
29. Nooter, K., Brutel, R. G., Look, M. P., Wingerden, K. E., Henzen, L., Scheper, R. J., Flens, M. J., Klijn, J. G., Stoter, G., and Foekens, J. A. The prognostic significance of expression of the multidrug resistance-associated protein (MRP) in primary breast cancer. Br. J. Cancer, 76: 486-493, 1997.
30. Nooter, K., Riviere, G. B., Klijn, J., Stoter, G., and Foekens, J. Multidrug resistance protein in recurrent breast cancer. Lancet, 349: 1885-1886, 1997.
31. Izquierdo, M. A., van der Zee, A. G., Vermorken, J. B., van der Valk, P., Belien, J. A., Giaccone, G., Scheffer, G. L., Flens, M. J., Pinedo, H. M., Kenemans, P., Meijer, C. L. M., and de Vries, E. G. E. Drug resistance associated marker Lrp for prediction of response to chemotherapy and prognoses in advanced ovarian carcinoma. J. Natl. Cancer Inst., 87: 1230-1237, 1995.
32. Yao, K. S., Xanthoudakis, S., Curran, T., and O'Dwyer, P. Activation of AP-1 and of a nuclear redox factor, Ref-1, in the response of HT29 colon cancer cells to hypoxia. Mol. Cell. Biol., 14: 5997-6003, 1994.
33. Bergelson, S., Pinkus, R., and Daniel, V. Intracellular glutathione levels regulate fos/jun induction and activation od glutathione S-transferase gene expression. Cancer Res., 54: 36-40, 1994.
34. Norris, M. D., Bordow, S. B., Haber, P. S., Marshall, G. M., Kavallaris, M. K., Madafiglio, J., Cohn, S. L., Salwen, H., Scmidt, M. L., Hipfner, D. R., Cole, S. P. C., Deeley, R. G., and Haber, M. Evidence that MYCN oncogene regulates mrp gene expression in neuroblastoma. Eur. J. Cancer, 33: 1911-1916, 1997.
35. Kurokawa, H., Ishida, T., Nishio, K., Arioka, H., Sata, M., Fukumoto, H., Miura, M., and Saijo, N. γ-glutamylcysteine synthetase gene overexpression results in increased activity of the ATP-dependent glutathione S-conjugate export pump and cisplatin resistance. Biochem. Biophys. Res. Commun., 216: 258-264, 1995.
36. Kigawa, J., Minagawa, Y., Kanamori, Y., Itamochi, H., Cheng, X., Okada, M., Oishi, T., and Terakawa, N. Glutathione concentration may be a useful predictor of second-line chemotherapy in patients with ovarian cancer. Cancer (Phila.), 82: 697-702, 1998.